
|Videos|April 7, 2016
Patient-Specific Factors to Consider When Selecting a Novel Oral Anticoagulant
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about patient-specific factors to consider when selecting a novel oral anticoagulant.
Advertisement
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about patient-specific factors to consider when selecting a novel oral anticoagulant.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Nipah Outbreak in India Poses Low Global Risk Despite Lack of Approved Treatments
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Q&A: Making Plant-Based Eating Practical in Pharmacy-Led Cardiometabolic Care
5


























